Aneurysm Diagnostic And Treatment Market
Global Aneurysm Diagnostic And Treatment Market Size, Share & Trends Analysis Report by Location (Aortal Aneurysm, Cerebral Aneurysm, Peripheral Aneurysm, Popliteal Aneurysm, Splenic Aneurysm, Mesenteric Aneurysm, and Others), by Bulge Shape (Fusiform Aneurysm and Saccular Aneurysm), by Treatment Approach (Open Surgery, Endovascular Stent Graft Surgery, and Medications), by Diagnosis Method (CT Scans and MRI, X-Ray), and by End-Users (Hospitals, Research Institute, and Diagnosis Institutes) Forecast Period (2022-2028)
The global aneurysm diagnostic and treatment market is anticipated to grow at a significant CAGR of 12% during the forecast period. Aneurysms are a medical condition that weakens the wall of arteries and causes abnormal outward bulging. Its treatment involves location-specific surgeries and medication to aid the surgery process to some extent. The rising prevalence of aneurysms due to unhealthy lifestyles, hypertension, smoking, and consumption of alcohol has been the major factor driving the market growth. Hypertension or elevated blood pressure is the main cause of the increase in the risk of heart attack, brain, kidney, and other diseases. Hypertension problem is attributed as another factor to propelling the market. As per the World Health Organisation in 2020, 1.13 billion people worldwide have hypertension, and two-thirds live in middle-income countries. Additionally, the increase in the number of smokers is another factor driving the market for people with a history of smoking accounting for about 75% of aortic aneurysms. However, the high cost of surgical procedures is likely to harm the growth of the aneurysm diagnostic and treatment market during the forecast period.
Additionally, the increasing geriatric population and rising cases of hypertension and diabetes associated with them are other factors driving the market growth. Moreover, the high prevalence of smokers and alcohol consumers who are most prone to this disease has been boosting the market. For instance, as per the Centers for Disease Control and Prevention, in 2019, around 14 of every 100 US adults of age 18 years or above-smoked cigarettes, which is 14% or 34.1 million adults.
Impact of COVID-19 Pandemic on Global Aneurysm Diagnostic And Treatment Market
The Aneurysm Diagnostic And Treatment market is hit by the outbreak of COVID-19 in December 2019. It has a sudden and dramatic impact on healthcare. The pandemic has had an impact on how people function and how different surgical procedures are performed. The number of aneurysm surgeries has significantly declined during the pandemic, due to the strict guidelines by the regulatory authorities to avoid all non-emergent surgeries. The outbreak of COVID-19 has disrupted the supply of raw materials and products across the globe. As doctors’ frontline warriors fighting against COVID-19, all other treatment procedures were postponed except in emergency cases. The COVID-19 pandemic shows severe symptoms in people, who are already suffering from chronic disease. This has impacted that people did not visit the hospital not to get exposed to the virus.
Segmental Outlook
The global aneurysm diagnostic and treatment market is segmented based on location, bulge shape, treatment approach, diagnosis method, and end-user. Based on the location, the market is segmented into an aortal aneurysm, cerebral aneurysm, peripheral aneurysm, popliteal aneurysm, scenic aneurysm, mesenteric aneurysm, and others (visceral). Based on the bulge shape, the market is segmented into a fusiform aneurysm and a saccular aneurysm. Based on the treatment approach, the market is segmented into surgery, endovascular stent graft surgery, and medications. Based on the diagnosis method, it is segmented into CT Scans, MRIs, and X-rays. Apart from this, by end-users, the market is segmented into hospitals, research institutes, and diagnosis institutes.
Global Aneurysm Diagnostic and Treatment Market Share by Treatment Approach, 2021 (%)
The Surgery Segment is Anticipated to Hold a Significant Share of the Market
Among the treatment for aneurysm diagnostic, the endovascular scale graft surgery segment is anticipated to cater significant share in 2021 and is also anticipated to grow during the forecast period. The factor contributing to the growth of endovascular scale graft surgery is technological advancement in its design. Moreover, more advanced graft systems are being launched by the companies operating in the segment with inbuilt imaging contributing to the growth of the market.
Regional Outlooks
The global aneurysm diagnostic and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others, and the Rest of the World (the Middle East and Africa, and Latin America). North America has been predicted to dominate the global Aneurysm Diagnostic and Treatment market due to its well-established health infrastructure, development in technology, support from the government, and also the region has a high number of hypertension patients and people with obesity problems. As per the Centre For disease control and prevention, only 1 in 4 adults with hypertension has their condition under control. Hypertension leads to the risk of heart disease and strokes which is a leading cause of death in the US.
Global Aneurysm Diagnostic and Treatment Market Growth, by Region, 2022-2028
Asia-Pacific is projected to have a Prominent Share in the global Aneurysm Diagnostic and Treatment Market
Asia-Pacific is anticipated to hold a considerable market share in the global Aneurysm Diagnostic and Treatment market. In the region, China and India are showing rapid progress. The rising geriatric population, increasing incidence, and prevalence rate of smokers are the factors that are growing the market demand in the region. According to WHO, in 2019, in China, there are more than 300 million smokers which are 1/3 of the world’s total. More than half of the adults are smokers in China. In addition, one in every third of cigarettes in the world is smoked in China. According to the American Thoracic Society, China is the world's largest manufacturer and consumer of tobacco products, producing more than 34.8 million packs of cigarettes and shipping 34.7 million cartons per year.
Market Players Outlook
The key players operating in the global aneurysm diagnostic and treatment market are Terumo Corp., Bentley, Cardinal Health, Indospan Ltd., PDS Biotechnology, and Raumedic AG, among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2020, Emdospan was granted a breakthrough device designation from the U. S Food and Drug Administration FDA for the NEXUS Aortic Arch Stent Graft System. In August 2020, Raumedic AG announced that it is planning to expand its medical tubing production capacities at its site in Feuchtwangen, Germany. The expansion is too intent to meet the increased demand for components used in infusion and feeding applications.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global aneurysm diagnostic and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Aneurysms Diagnostic and Treatment Industry
- Recovery Scenario of Global Global Aneurysms Diagnostic and Treatment Industry
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.By Region
2. Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3. Competitive Landscape
3.1.Key Company Analysis
3.1.1.Overview
3.1.2.Financial Analysis
3.1.3.SWOT Analysis
3.1.4.Recent Developments
3.2.Key Strategy Analysis
3.3.Impact of COVID-19 on Key Players
4. Market Determinants
4.1.Motivators
4.2.Restraints
4.3.Opportunities
5. Market Segmentation
5.1.Global Aneurysms Diagnostic and Treatment Market by Location
5.1.1.Aortal Aneurysms
5.1.2.Cerebral Aneurysms
5.1.3.Peripheral Aneurysms
5.1.4.Popliteal Aneurysms
5.1.5.Splenic Aneurysms
5.1.6.Mesenteric Aneurysms
5.1.7.Others (Visceral)
5.2.Global Aneurysms Diagnostic and Treatment Market by Bulge Shape
5.2.1.Fusiform Aneurysms
5.2.2.Saccular Aneurysms
5.3.Global Aneurysms Diagnostic and Treatment Market by Treatment Approach
5.3.1.Open surgery
5.3.2.Endovascular stent-graft surgery
5.3.3.Medications
5.4.Global Aneurysms Diagnostic and Treatment Market by Diagnosis Method
5.4.1.CT Scan
5.4.2.MRI Scans
5.4.3.X-Ray
5.5.Global Aneurysms Diagnostic and Treatment Market by End-Users
5.5.1.Hospitals
5.5.2.Research Institutes
5.5.3.Diagnostic Institutes
6. Regional Analysis
6.1.North America
6.1.1.United States
6.1.2.Canada
6.2.Europe
6.2.1. the UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3.Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4.Rest of the World
7. Company Profiles
7.1Bentley
7.2.Braile Biomedical
7.3.Cardinal Health
7.4.PDS Biotechnology
7.5.Endospan Ltd.
7.6.Infrascan, Inc.
7.7.Integra Life Sciences Corp.
7.8.Johnson & Johnson, Inc.
7.9.JOTEC GmbH
7.10. Lombard Medical, Inc.
7.11.Medtronic PLC
7.12.Microport Scientific Corp.
7.13.Raumedic AgG
7.14.Sophysa Ltd.
7.15.Spiegelberg GmbH
7.16.Terumo Corp.
7.17.Vascops Gmbh
7.18 W. L. Gore & Associates, Inc.
1.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY LOCATION, 2021-2028 ($ MILLION)
2.GLOBAL AORTAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL CEREBRAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL PERIPHERAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5.GLOBAL POPLITEAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL SPLENIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7.GLOBAL MESENTERIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8.GLOBAL OTHERS (VISCERAL) ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY BULGE SHAPE, 2021-2028 ($ MILLION)
10.GLOBAL FUSIFORM ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11.GLOBAL SACCULAR ANEURYSMS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT APPROACH, 2021-2028 ($ MILLION)
13.GLOBAL OPEN SURGERY FOR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14.GLOBAL ENDOVASCULAR STENT GRAFT SURGERY FOR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15.GLOBAL MEDICATION FOR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2021-2028 ($ MILLION)
17.GLOBAL CT SCANS FOR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18.GLOBAL MRI FOR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
19.GLOBAL X-RAYS FOR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
21.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
22.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT IN RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
23.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT IN DIAGNOSIS INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
24.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
25.NORTH AMERICAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
26.NORTH AMERICAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY LOCATION, 2021-2028 ($ MILLION)
27.NORTH AMERICAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY BULGE SHAPE, 2021-2028 ($ MILLION)
28.NORTH AMERICAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT APPROACH, 2021-2028 ($ MILLION)
29.NORTH AMERICAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2021-2028 ($ MILLION)
30.NORTH AMERICAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
31.EUROPEAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
32.EUROPEAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY LOCATION, 2021-2028 ($ MILLION)
33.EUROPEAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY BULGE SHAPE, 2021-2028 ($ MILLION)
34.EUROPEAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT APPROACH, 2021-2028 ($ MILLION)
35.EUROPEAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2021-2028 ($ MILLION)
36.EUROPEAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
37.ASIA-PACIFIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
38.ASIA-PACIFIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY LOCATION, 2021-2028 ($ MILLION)
39.ASIA-PACIFIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY BULGE SHAPE, 2021-2028 ($ MILLION)
40.ASIA-PACIFIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT APPROACH, 2021-2028 ($ MILLION)
41.ASIA-PACIFIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2021-2028 ($ MILLION)
42.ASIA-PACIFIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
43.REST OF THE WORLD ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
44.REST OF THE WORLD ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY LOCATION, 2021-2028 ($ MILLION)
45.REST OF THE WORLD ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY BULGE SHAPE, 2021-2028 ($ MILLION)
46.REST OF THE WORLD ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT APPROACH, 2021-2028 ($ MILLION)
47.REST OF THE WORLD ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS METHOD, 2021-2028 ($ MILLION)
REST OF THE WORLD ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET, 2022-2028 (%)
4.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY LOCATION, 2021 VS 2028 (%)
5.GLOBAL AORTAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2020 VS 2027(%)
6.GLOBAL CEREBRAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
7.GLOBAL PERIPHERAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
8.GLOBAL POPLITEAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
9.GLOBAL SPLENIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
10.GLOBAL MESENTERIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
11.GLOBAL OTHERS (VISCERAL) IN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
12.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY BULGE SHAPE, 2021 VS 2028 (%)
13.GLOBAL FUSIFORM ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
14.GLOBAL SACCULAR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
15.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY TREATMENT APPROACH 2021 VS 2028 (%)
16.GLOBAL SURGERY IN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
17.GLOBAL ENDOVASCULAR STENT GRAFT SURGERY IN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
18.GLOBAL MEDICATIONS IN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
19.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY DIAGNOSIS METHOD, 2021 VS 2028 (%)
20.GLOBAL CT SCANS FOR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
21.GLOBAL MRI FOR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
22.GLOBAL X-RAYS FOR ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
23.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY END-USERS, 2021 VS 2028 (%)
24.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT IN HOSPITALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
25.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT IN RESEARCH INSTITUTE SHARE BY REGION, 2021 VS 2028 (%)
26.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT IN DIAGNOSIS INSTITUTES MARKET SHARE BY REGION, 2021 VS 2028 (%)
27.GLOBAL ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
28.US ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
29.CANADA ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
30.UK ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
31.FRANCE ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
32.GERMANY ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
33.ITALY ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
34.SPAIN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
35.REST OF EUROPE ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
36.INDIA ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
37.CHINA ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
38.JAPAN ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
39.SOUTH KOREA ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
40.REST OF ASIA-PACIFIC ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
41.REST OF THE WORLD ANEURYSMS DIAGNOSTIC AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
